最近纳米粒子的进步,针对TGF-β信号传递,用于癌症治疗
Ziying Li1, Xugang Ji1, Xiaoyi Cong1
1Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, Zhejiang Normal University, Jinhua 321004, China.
Theranostics
|January 29, 2026
概括
改变癌症治疗:纳米颗粒精确地准转化增长因子-β (TGF-β) 信号,克服系统性副作用并增强药物输送以提高抗瘤疗效.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 转化生长因子-β (TGF-β) 信号在癌症中起着复杂的双重作用,对全身封锁疗法提出了挑战.
- 由于这些系统性影响和复杂的瘤微环境,TGF-β抑制剂的临床试验结果令人失望.
- 纳米技术提供了一个有希望的途径,通过有针对性的交付系统来克服这些局限性.
研究的目的:
- 审查TGF-β信号传导在癌症中的多方面的作用.
- 总结目前抑制TGF-β信号传递的策略.
- 强调基于纳米粒子的先进策略,以针对性地阻断TGF-β并增强药物输送.
主要方法:
- 对TGF-β信号通路及其治疗向的文献综述.
- 对TGF-β抑制剂的临床前和临床数据的分析.
- 探索纳米粒子工程的刺激响应和向药物输送.
- 讨论TGF-β阻断和纳米粒子传递效率之间的相互作用.
主要成果:
- TGF-β在癌症中表现出复杂的,取决于情境的作用,需要精确的治疗干预.
- 设计用于TGF-β向的纳米粒子可以增强瘤微环境中的药物透和输送.
- 在TGF-β阻塞改善纳米粒子传递,纳米粒子完善TGF-β准特异性的情况下存在协同关系.
结论:
- 智能纳米输送系统提供了一种空间控制TGF-β抑制的策略,减轻系统性毒性.
- 在TGF-β阻塞和纳米粒子输送之间的相互增强具有促进抗瘤疗法的巨大潜力.
- 对纳米粒子设计和TGF-β向的进一步研究对于临床转化至关重要.
相关概念视频
01:16TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:57Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
03:03mTOR Signaling and Cancer Progression
4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.8K
02:03What is Cell Signaling?
130.3K
Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
130.3K
01:45Endocrine Signaling
68.1K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.1K